Aktuell 24 mai 2024 Geistlich erhält EU-Zertifizierung für Kollagen-Portfolio Geistlich Pharma hat die MDR-Zertifizierung für seine Kollagen-Produktpalette erhalten und erfüllt damit die neuen EU-Vorschriften. Die Produkte ...
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 10 mai 2024 Flumroc melts rock using hydropower Flumroc from the canton of St.Gallen has put on stream the world’s largest electric melting furnace for stone wool. The furnace runs entirely on ...
News 12 jan 2024 Hybridbox wins Watt d'Or award The Swiss Federal Office of Energy awarded this year's Watt d'Or prize on 11 January. Among the winners is the SEK Mättmi project, which features...
Aktuell 12 jan 2024 Hybridbox wird mit Watt d‘Or ausgezeichnet Das Bundesamt für Energie hat am 11. Januar den diesjährigen Preis Watt d’Or vergeben. Zu den Preisträgern gehört auch das Projekt SEK Mättmi mit...
Actualités 26 jun 2023 Le premier parc solaire flottant en milieu alpin du monde livre ses résultats Romande Energie, le principal fournisseur d’énergie de Suisse occidentale, a publié les résultats du premier parc solaire flottant en milieu alpi...
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 11 jul 2023 Alporit on the cusp of launching halogen-free insulating panels Alporit AG is planning to launch insulating panels on the market without the use of halogens for fire protection. During the development process,...
News 13 mar 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités 26 mar 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
Actualités 12 jan 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 10 out 2023 MSD bekennt sich zum Standort Luzern MSD Schweiz will von Luzern aus weiter wachsen. Seit seiner Gründung vor 60 Jahren hat das Pharmaunternehmen kantonsweit eine halbe Milliarde Fr...
News 14 fev 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 05 set 2023 Torqeedo and c.technology enter into partnership Torqeedo, a German company specializing in electric drive systems for water vehicles, and c.technology are collaborating. The company from the Gr...
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...